Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial

Author:

Goede Lukas L.12ORCID,Oxenford Simon1,Kroneberg Daniel12ORCID,Meyer Garance M.3,Rajamani Nanditha1,Neudorfer Clemens3,Krause Patricia1ORCID,Lofredi Roxanne12ORCID,Fox Michael D.3,Kühn Andrea A.14567,Horn Andreas138

Affiliation:

1. Department of Neurology with Experimental Neurology, Charité‐Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

2. BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program Berlin Institute of Health at Charité‐Universitätsmedizin Berlin Berlin Germany

3. Center for Brain Circuit Therapeutics, Department of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

4. Bernstein Center for Computational Neuroscience Humboldt‐Universität Berlin Germany

5. NeuroCure, Exzellenzcluster Charité‐Universitätsmedizin Berlin Berlin Germany

6. DZNE, German Center for Neurodegenerative Diseases Berlin Germany

7. Berlin School of Mind and Brain Humboldt‐Universität zu Berlin Berlin Germany

8. MGH Neurosurgery & Center for Neurotechnology and Neurorecovery (CNTR) at MGH Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

Abstract

AbstractBackgroundRecent imaging studies identified a brain network associated with clinical improvement following deep brain stimulation (DBS) in Parkinson's disease (PD), the PD response network.ObjectivesThis study aimed to assess the impact of neuromodulation on PD motor symptoms by targeting this network noninvasively using multifocal transcranial direct current stimulation (tDCS).MethodsIn a prospective, randomized, double‐blinded, crossover trial, 21 PD patients (mean age 59.7 years, mean Hoehn & Yahr [H&Y] 2.4) received multifocal tDCS targeting the a‐priori network. Twenty‐minute sessions of tDCS and sham were administered on 2 days in randomized order. Movement Disorder Society‐Unified Parkinson's Disease Rating Scale—Part III (MDS‐UPDRS‐III) scores were assessed.ResultsBefore intervention, MDS‐UPDRS‐III scores were comparable in both conditions (stimulation days: 37.38 (standard deviation [SD] = 12.50, confidence interval [CI] = 32.04, 42.73) vs. sham days: 36.95 (SD = 13.94, CI = 30.99, 42.91), P = 0.63). Active stimulation resulted in a reduction by 3.6 points (9.7%) to 33.76 (SD = 11.19, CI = 28.98, 38.55) points, whereas no relevant change was observed after sham stimulation (36.43 [SD = 14.15, CI = 30.38, 42.48], average improvement: 0.5 [1.4%]). Repeated‐measures analysis of variance (ANOVA) confirmed significance (main effect of time: F(1,20)=4.35, P < 0.05). Tukey's post hoc tests indicated MDS‐UPDRS‐III improvement after active stimulation (t [20] = 2.9, P = 0.03) but not after sham (t [20] = 0.42, P > 0.05). In a subset of patients that underwent DBS surgery later, their DBS response correlated with tDCS effects (R = 0.55, P(1) = 0.04).ConclusionNoninvasive, multifocal tDCS targeting a DBS‐derived network significantly improved PD motor symptoms. Despite a small effect size, this study provides proof of principle for the successful noninvasive neuromodulation of an invasively identified network. Future studies should investigate repeated tDCS sessions and their utility for screening before DBS surgery. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Funder

Deutsche Forschungsgemeinschaft

National Institutes of Health

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3